Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

LUMEFANTRINE ARTEME

Active
SPE2DP-26-T-4073Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Artemether-lumefantrine tablets, marketed under the brand name Coartem by Novartis Pharmaceuticals Corporation, are specified for the treatment of acute uncomplicated malaria in adults and children weighing at least 11 pounds (5 kg). Each tablet contains 20 milligrams of artemether and 120 milligrams of lumefantrine as active ingredients, and the unit of issue is a bottle containing 24 tablets. The product must have a minimum of 21 months of remaining shelf life upon receipt by the first government activity, with a total shelf life of 24 months, and must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F). All packaging and labeling must comply fully with Medical Marking Standard No. 1, superseding MIL-STD-129, and must be commercially packaged in accordance with ASTM D3951 unless overridden by higher-priority DLA technical requirements. The material is not classified as hazardous under FED-STD-313 and must be shipped by the fastest traceable means, excluding parcel post, with delivery required within five days at the destination point of Fort Bragg, North Carolina. The contract requires strict adherence to the DLA Master List of Technical and Quality Requirements, with no variance permitted in quantity, as the order is for exactly 26 bottles. The item is regulated by the FDA and carries the NSN 6505-01-573-6500, and all packaging must be marked in accordance with the latest version of Medical Marking Standard No. 1, available through the DLA website. The solicitation is managed under contract SPE2DP-26-T-4073 with a required delivery date of July 13, 2026, and response deadline of July 20, 2026.

General Info

26 bottles of Coartem tablets, 20/120 mg, 21-month shelf life, FDA-regulated, delivered to Fort Bragg by July 13, 2026

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

423450 - Medical, Dental, and Hospital Equipment and Supplies Merchant WholesalersView NAICS

Place of Performance

5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4073 Request for Quotations

PDFrfq

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts

Full Description

Show more
LUMEFANTRINE ARTEME
ARTEMETHER-LUMEFANTRINE TABLETS,.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RX ONLY, FOR ORAL ADMINISTRATION. USED TO TREAT ACUTE UNCOMPLICATED
MALARIA IN ADULTS AND CHILDREN WHO WEIGH AT LEAST 11 POUNDS (5 KG)..
EACH TABLET CONTAINS 20 MILLIGRAMS (MG) OF ARTEMETHER AND 120 MG OF
LUMEFANTRINE AS THE ACTIVE INGREDIENTS.. UNIT OF ISSUE IS A BOTTLE
CONTAINING 24 TABLETS.. TOTAL SHELF LIFE IS 24 MONTHS.. THERE SHALL BE
A MINIMUM OF 21 MONTHS OF REMAINING SHELF LIFE AT THE TIME OF RECEIPT BY
THE FIRST GOVERNMENT ACTIVITY.. STORE AT 20° TO 25°C (68° TO 77°F) [SEE
USP CONTROLLED ROOM TEMPERATURE].
. 5/1/2017.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-4073
SECTION B
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
NOVARTIS PHARMACEUTICALS CORPORATION 04520 P/N COARTEM NOVARTIS PHARMACEUTICALS CORPORATION 04520 P/N NDC00078-0568-45
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017435974 0001 BT 26.000
NSN/MATERIAL:6505015736500
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
SPE2DP-26-T-4073
SECTION B
PR: 7017435974 PRLI: 0001 CONT’D
FORT BRAGG NC 28310
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
MARKFOR
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
M/F: (TCN) W91KBP61890022
RDD: 203
PROJ: TP 1
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:07/13/2026
SPE2DP-26-T-4073 NSN/Part Number: 6505-01-573-6500 Quantity: 26 BT Purchase Request: 7017435974QTY: 26 Delivery: 5 days ADO

Similar Contracts

NAICS: 423450
New
DIBBS
SURGICAL PACK, DISPOThis contract specifies the procurement of a disposable obstetrical surgical pack designated as SURGICAL PACK, DISPOSABLE, OB, with a unit of issue defined as a pack of six complete sets. Each pack contains essential sterile items for obstetrical procedures including a table cover, obstetrical gown with towel, absorbent towels, reinforced under buttocks drape, abdominal drape, legging drapes, obstetrical pads, 4x4 inch x-ray detectable gauze sponges, vaginal packing, Hollister double grip cord clamp, placenta basin, baby blanket, and bulb syringe. The pack must be nonwoven, sterile, and fully compliant with DLA packaging and technical requirements as outlined in the DLA Master List of Technical and Quality Requirements. All units must be individually sealed in commercial-grade packaging meeting Medical Marking Standard No. 1, superseding MIL-STD-129, and shipped in exterior containers that ensure safe delivery via common carrier at the lowest cost to the designated delivery point. The contract mandates strict compliance with FDA regulations as this is a regulated medical device, requiring confirmation through EBS referral for each bidder. The specified NSN is 6515-01-523-2451, with a purchase quantity of 15 packs, each priced at $15.00 for a total contract value of $225. Delivery is FOB destination within 20 days, with zero variance allowed in quantity and inspection and acceptance occurring at the delivery point. Packaging must conform to MIL-STD-2073-1E, and marking instructions must follow DLA’s Medical Marking Standard No. 1. Approved suppliers include TWO RIVERS MEDICAL and MEDLINE INDUSTRIES INC., both offering part number DYNJP6010. The solicitation, issued under contract number SPE2DH-26-T-5131, is posted by the Department of Defense’s Medical Supply Chain FSH with Tina Vu as the point of contact, and responses are due by July 20, 2026.
MEDICAL SUPPLY CHAIIN FSH

POSTED

about 13 hours ago

DEADLINE

in 7 days
View Details
NAICS: 423450
New
DIBBS
SODIUM CHLORIDE INJSodium Chloride Injection in 10 mL disposable syringes, preservative-free and latex-free, is being procured under solicitation SPE2DP-26-T-4082 with a total quantity of 4 units of issue (PG), where each PG equals 30 syringes, totaling 120 syringes. The product is packaged in trays of 30 syringes each and must comply with the DLA Master List of Technical and Quality Requirements, superseding all other standards including MIL-STD-129, which has been replaced by Medical Marking Standard No. 1 for labeling and packaging. All packaging must be commercial-grade, secure, and designed to prevent damage during transit, with palletization governed by RP001 requirements. The item is not classified as hazardous under FED-STD-313 and must be packaged per ASTM D3951 unless a higher DLA requirement applies. Each unit must be marked in strict accordance with Medical Marking Standard No. 1, and shipment must occur via the fastest traceable method, excluding parcel post. The product has a fixed 24-month shelf life with no extension allowed and must be delivered FOB destination within five days of shipment. Two distinct delivery points are specified: one in East Greenwich, Rhode Island, and another in Fort Bragg, North Carolina, each with unique shipping addresses and tracking identifiers. The contractor, AmerisourceBergen Drug Corp, must provide the item under part number 106346 with the NSN 6505015955160, and all documentation must align with DLA’s unit of issue standards as referenced in their official documentation. The item is FDA-regulated, requiring referral to a product specialist for confirmation prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 7 days
View Details
NAICS: 423450
New
DIBBS
TEST TUBE, BLOOD COLLECThe contract specifies the procurement of vacuum blood collection test tubes, 7 mL capacity, with sodium fluoride (30 mg) as an additive, gray cap, glass construction, and packaged in units of 100 per package. The item has a mandatory 45-month shelf life, with no more than eight months allowed to have passed from the date of manufacture to the date of delivery to the government. All packaging must comply with commercial standards as outlined in the procurement document, ensuring each unit is sealed in a container that prevents damage or breakage, and all shipping containers must be suitable for safe delivery via common carriers at the lowest cost to the designated delivery point. Packaging and labeling must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must include the NSN, manufacturer and CAGE code, date of manufacture or expiration, contract number, and lot number. The product is regulated by the FDA, requiring referral to a product specialist for confirmation. The delivery is FOB destination within 20 days of order, with zero variance allowed in quantity, and inspection and acceptance occur at the point of delivery. The shipping address is designated for APO AE 09094-3219 and Ramstein, Germany, with specific transportation guidelines referenced. The item is identified by NSN 6640-00-145-1534 and is subject to all applicable DLA technical and quality requirements as defined in the DLA Master List.
MEDICAL SUPPLY CHAIIN FSH

POSTED

about 13 hours ago

DEADLINE

in 7 days
View Details